Genomenon Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 170

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $5.46M

  • Investors
  • 25

Genomenon General Information

Description

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software offers a set of diagnostic and discovery tools to identify disease-causing genomic variants and assists in treating cancer and other inheritable diseases, enabling physicians to improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 206 East Huron Street
  • Suite 114
  • Ann Arbor, MI 48104
  • United States
+1 (734)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Oncology
Corporate Office
  • 206 East Huron Street
  • Suite 114
  • Ann Arbor, MI 48104
  • United States
+1 (734)

Genomenon Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomenon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series B1) 16-May-2024 $5.46M Completed Generating Revenue
14. Later Stage VC (Series B) 25-Feb-2022 Completed Generating Revenue
13. Grant 15-Feb-2022 Completed Generating Revenue
12. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
11. Later Stage VC (Series A) 16-Mar-2021 Completed Generating Revenue
10. Debt - PPP 07-Apr-2020 Completed Generating Revenue
9. Grant 01-May-2019 Completed Generating Revenue
8. Seed Round 08-Jan-2019 Completed Generating Revenue
7. Seed Round 07-Jul-2018 $1.25M $3.5M Completed Generating Revenue
6. Grant 25-Apr-2017 $1.8M $2.25M Completed Generating Revenue
To view Genomenon’s complete valuation and funding history, request access »

Genomenon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A
Seed 1 1,303,131 $0.000100 $1.9 $1.9 1x $1.9 9.31%
Seed 1,590,190 $0.000100 $1.71 $1.71 1x $1.71 11.36%
To view Genomenon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genomenon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software o
Discovery Tools (Healthcare)
Ann Arbor, MI
170 As of 2024

Baltimore, MD
 

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genomenon Competitors (26)

One of Genomenon’s 26 competitors is Personal Genome Diagnostics, a Formerly VC-backed company based in Baltimore, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
DNAnexus Venture Capital-Backed Mountain View, CA
Nebula Genomics Formerly VC-backed Garden City, NY
Second Genome Formerly VC-backed Brisbane, CA
Deep Genomics Venture Capital-Backed Toronto, Canada
You’re viewing 5 of 26 competitors. Get the full list »

Genomenon Patents

Genomenon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230298769-A1 Systems and methods for gene variant grouping and visualization Pending 10-Apr-2020

Genomenon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomenon Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beringea Venture Capital Minority
P93 Ventures Venture Capital Minority
Spring Mountain Capital Growth/Expansion Minority
The 4100 Group Other Private Equity Minority
Small Business Innovation Research and Small Business Technology Transfer Programs Government
You’re viewing 5 of 25 investors. Get the full list »

Genomenon Acquisitions (1)

Genomenon’s most recent deal was a Merger/Acquisition with Boston Genetics. The deal was made on 27-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Boston Genetics 27-Jun-2023 Merger/Acquisition BPO/Outsource Services
To view Genomenon’s complete acquisitions history, request access »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Boston Genetics Cambridge, MA 2019

Genomenon FAQs

  • When was Genomenon founded?

    Genomenon was founded in 2014.

  • Where is Genomenon headquartered?

    Genomenon is headquartered in Ann Arbor, MI.

  • What is the size of Genomenon?

    Genomenon has 170 total employees.

  • What industry is Genomenon in?

    Genomenon’s primary industry is Discovery Tools (Healthcare).

  • Is Genomenon a private or public company?

    Genomenon is a Private company.

  • What is the current valuation of Genomenon?

    The current valuation of Genomenon is .

  • What is Genomenon’s current revenue?

    The current revenue for Genomenon is .

  • How much funding has Genomenon raised over time?

    Genomenon has raised $36.8M.

  • Who are Genomenon’s investors?

    Beringea, P93 Ventures, Spring Mountain Capital, The 4100 Group, and Small Business Innovation Research and Small Business Technology Transfer Programs are 5 of 25 investors who have invested in Genomenon.

  • Who are Genomenon’s competitors?

    Personal Genome Diagnostics, DNAnexus, Nebula Genomics, Second Genome, and Deep Genomics are some of the 26 competitors of Genomenon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »